An observational study in Hypothyroidism, sponsored by Birte Nygaard. Completed at 1 site in Denmark. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-03-18.
Sponsored by Birte Nygaard · Observational
The aim of the study was to evaluate the clinical control program in patients with hypothyroidism during pregnancy (suggested in resent guidelines). Is it possible by monitoring the patients every 4. week during pregnancy to keep the thyroid function parameters within the recommended range?
A retrospective study of consecutive pregnant women with hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012. Patients selected through electronic medical system. Blood tests for the The hormone levels drawn from the laboratory of Clinical Biochemical Department, Herlev Hospital
247 studies on the registry are indexed under Hypothyroidism; 57 are open to participants now.
This study's enrollment of 80 is below the median of 148 across 104 observational studies indexed under Hypothyroidism.
Browse Hypothyroidism studies →This is the only study on the registry with Birte Nygaard as lead sponsor.
Counted across the registry records on this site, refreshed daily.
A retrospective study of consecutive pregnant women with L-T4 treated hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012
Inclusion Criteria:
L-T4 treated pregnant women
Other: biomedical outcomes
Evaluation of abnormal blodtests (evaluating thyroid function) from predefined control program
number of patients with thyroid function parameters within the intended level
Time frame: nine months
number of complications during pregnancy
Time frame: nine months
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.